Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Diabetologia|March 1, 2023
Identifying blood biomarkers for type 2 diabetes subtyping: a report from the ORIGIN trialMarie Pigeyre, Hertzel Gerstein, Emma Ahlqvist, et al.Diabetes Research and Clinical Practice|November 13, 2023
Sex hormone-binding globulin and heart failure hospitalizations in patients with dysglycemia: Experiences from the outcome reduction with an Initial Glargine Intervention trialAnne Wang, Sibylle Hess, Shun Fu Lee, et al.Circulation. Genomic and Precision Medicine|January 14, 2020
Identification of Circulating Proteins Associated With Blood Pressure Using Mendelian RandomizationSébastien Thériault, Jennifer Sjaarda, Michael Chong, et al.The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic PeopleHertzel C Gerstein, Guillaume Paré, Matthew J McQueen, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2004
Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarctionGabi Busch, Isabell Seitz, Birgit Steppich, et al.Diabetes, Obesity & Metabolism|July 3, 2026
A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at BaselineHertzel C Gerstein, Zayeeda Labiba, Sibylle Hess, et al.Journal of Combinatorial Chemistry|March 15, 2005
Evolutionary chemistry approach toward finding novel inhibitors of the type 2 diabetes target glucose-6-phosphate translocaseSilke Bräuer, Michael Almstetter, Walfrido Antuch, et al.Journal of Alzheimer'S Disease : JAD|April 18, 2022
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN TrialTali Cukierman-Yaffe, Shun-Fu Lee, Guillaume Pare, et al.Diabetologia|October 22, 2021
Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trialMarie Pigeyre, Sibylle Hess, Maria F Gomez, et al.European Heart Journal|May 14, 2020
Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trialWolfram Doehner, Hertzel C Gerstein, Janina Ried, et al.Pageof 4